EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interferon-stimulated neutrophils as a predictor of immunotherapy response

Madeleine Benguigui, Tim J Cooper, Prajakta Kalkar, Sagie Schif-Zuck, Ruth Halaban, Antonella Bacchiocchi, Iris Kamer, Abhilash Deo, Bar Manobla, Rotem Menachem, Jozafina Haj-Shomaly, Avital Vorontsova und 9 weitere

Cancer Cell · 2024-02 · 42 (2) · 253-265.e12

DOI: 10.1016/j.ccell.2023.12.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2024-02. Verfasst von Madeleine Benguigui und 20 weiteren Autor:innen. Beteiligte Einrichtung: Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Rappaport Technion Integrat…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 180-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the remarkable success of anti-cancer immunotherapy, its effectiveness remains confined to a subset of patients-emphasizing the importance of predictive biomarkers in clinical decision-making and further mechanistic understanding of treatment response. Current biomarkers, however, lack the power required to accurately stratify patients. Here, we identify interferon-stimulated, Ly6Ehi neutrophils as a blood-borne biomarker of anti-PD1 response in mice at baseline. Ly6Ehi neutrophils are induced by tumor-intrinsic activation of the STING (stimulator of interferon genes) signaling pathway and possess the ability to directly sensitize otherwise non-responsive tumors to anti-PD1 therapy, in part through IL12b-dependent activation of cytotoxic T cells. By translating our pre-clinical findings to a cohort of patients with non-small cell lung cancer and melanoma (n = 109), and to public data (n = 1440), we demonstrate the ability of Ly6Ehi neutrophils to predict immunotherapy response in humans with high accuracy (average AUC ≈ 0.9). Overall, our study identifies a functionally active biomarker for use in both mice and humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansMiceAnimalsInterferonsNeutrophilsBiomarkersImmunotherapy

Stichwörter der Autor:innen

BiomarkerSTINGimmunotherapyinterferonmelanomaneutrophilsnon-small cell lung cancerresponse

Substanzen

InterferonsBiomarkers

Autor:innen und Institutionen

  • Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Is…
  • Department of Human Biology, the Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
  • Department of Dermatology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
  • Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases (NCT) at Heidelberg University Hospital, 69126 Heidelberg, Germany; Translational Lung Research Center Heidelberg, Member of the Germa…
  • Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • H2020 European Research Council
  • Israel Science Foundation

Zitieren

APA

Benguigui, M., Cooper, T. J., Kalkar, P., Schif-Zuck, S., Halaban, R., Bacchiocchi, A., Kamer, I., Deo, A., Manobla, B., Menachem, R., Haj-Shomaly, J., Vorontsova, A., Raviv, Z., Buxbaum, C., Christopoulos, P., Bar, J., Lotem, M., Sznol, M., Ariel, A., …, & Shaked, Y. (2024). Interferon-stimulated neutrophils as a predictor of immunotherapy response. Cancer Cell, 42(2), 253-265.e12. https://doi.org/10.1016/j.ccell.2023.12.005

Vancouver

Benguigui M, Cooper TJ, Kalkar P, Schif-Zuck S, Halaban R, Bacchiocchi A, et al. Interferon-stimulated neutrophils as a predictor of immunotherapy response. Cancer Cell. 2024;42(2):253-265.e12. doi:10.1016/j.ccell.2023.12.005

BibTeX
@article{Benguigui2024,
  author = {Benguigui, Madeleine and Cooper, Tim J and Kalkar, Prajakta and Schif-Zuck, Sagie and Halaban, Ruth and Bacchiocchi, Antonella and Kamer, Iris and Deo, Abhilash and Manobla, Bar and Menachem, Rotem and Haj-Shomaly, Jozafina and Vorontsova, Avital and Raviv, Ziv and Buxbaum, Chen and Christopoulos, Petros and Bar, Jair and Lotem, Michal and Sznol, Mario and Ariel, Amiram and Shen-Orr, Shai S and Shaked, Yuval},
  title = {Interferon-stimulated neutrophils as a predictor of immunotherapy response},
  journal = {Cancer Cell},
  year = {2024},
  volume = {42},
  number = {2},
  pages = {253--265.e12},
  doi = {10.1016/j.ccell.2023.12.005}
}
Kostenlos starten →